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on mortality. We implement our method on Swedish data. We show that there
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that health policies that aim at decreasing smoking prevalence and quantities smoked
might have less e®ect in terms of average number of years of life gained than previously
estimated. We also empirically show that selection into smoking has increased over
the last ¯fty years with the availability of information on the dangers of smoking,
so that future studies comparing smokers and non smokers will spuriously reveal a
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21 Introduction
Smokers die on average younger than non smokers. This statement, usually substantiated
by contrasting the life expectancy of smokers and that of non smokers adjusting for some
individual characteristics, has formed, since the 1960s, the basis of government policies
designed to curb smoking on the grounds of the detrimental e®ect of smoking on health.
But the e®ect of tobacco on health can be inferred by comparing smokers and non smokers
only if smoking is a random choice so that individuals do not self select into smoking on
the basis of their health.
Although there is a large epidemiologic literature devoted to measuring the e®ect of
tobacco on health1, it shows limited concern for this question of selection into smoking.
This is probably because epidemiologists consider smoking as exogenous. A di®erent view
point has been adopted by the economic literature, which considers smoking as a choice,
following the health investment literature, pioneered by Grossman (1972) or the rational
addiction literature (Becker and Murphy (1988)). In this view, smoking may depend on
unobserved individual characteristics - such as the discount factor- that also in°uence
health through other channels. If this is the case, then traditional epidemiological studies
may yield misleading results as to the e®ect of tobacco on health. Rather surprisingly, the
economic literature has not pushed this point much further, with the notable exceptions
of Rosenzweig and Schultz (1983) and Evans and Ringel (1999), who consider the e®ect of
maternal smoking on birth weight, allowing for endogeneity. Both show that endogeneity
is important and should be accounted for.
If there is selection into smoking so that individuals with poorer health are more likely
to be smokers - which would lead to overstate the e®ect of tobacco on health - it would
have enormous economic consequences. Public policies, even if successful in decreasing
smoking prevalence, may not achieve large gains in life expectancy or large economies in
health expenditure. Smokers who quit or reduce their consumption of cigarettes would
1Studies dates back at least to the nineteen twenties (Broders (1920), Lombard and Doering (1928) or
Lickint (1935)). The seminal papers in the nineteen ¯fties and sixties, include the work of Doll and Hill
(1950) and Wynder and Graham (1950) (see also Doll and Hill (1954), Doll and Hill (1956) and Hammond
(1966). More recent estimates of the e®ect of tobacco on health include for instance Phillips et al. (1996)
or Peto et al. (2000).
3certainly face a lower risk of tobacco related diseases, such as lung cancers, but would not
necessarily see their life expectancy increase by large margins. This would also bear on
legal compensations, which may have to be revised downwards, as part of the observed
di®erence in average life expectancies of smokers and non smokers could be due to selection.
According to the World Health Organization, there are currently 1.25 billion smokers in
the world; among those, there are each year 4 million deaths from tobacco-related diseases
and it is forecast that there will be 10 million such deaths yearly by 2030; in other words
tobacco causes more deaths than malaria, tuberculosis and major childhood conditions
combined. A crucial policy question is whether preventing all these deaths will lead to
substantial gains in life expectancy. To quantify the costs due to the anticipated death
of smokers, it is necessary to measure the e®ect of tobacco on health, a task at which we
make here an attempt.
In this paper, we consider the identi¯cation of the e®ect of tobacco on health allowing
for the possibility of selection into smoking. While most of the literature has used data on
mortality and smoking behavior, we argue that identi¯cation is usually impossible using
such data alone. Our approach is to combine data on mortality and smoking behaviour
with detailed information on individual morbidity, together with medical and epidemio-
logical knowledge on morbidity. Our identi¯cation strategy is novel but very simple. We
use the additional information from the medical and epidemiological sciences to construct
a proxy for the underlying health of the individual, where the underlying health is de¯ned
as being their health had they not smoked. This is very similar in spirit to using test
scores to proxy for ability in wage equations.
We use an extensive data set, where 38000 Swedish individuals are followed for up to
eighteen years, recording their smoking behavior, other risky behaviors, mortality, a range
of morbidity indicators and information on individual and family characteristics such as
education, occupation and family income.
We present evidence of selection into smoking. We show that smokers come from a
population with poorer underlying health, even when conditioning on a number of observed
characteristics. This implies that the gains from reducing smoking are not as large as they
would be thought to be without accounting for selection into smoking. We also show that
there is a large heterogeneity in the e®ect of tobacco on mortality. The e®ect of tobacco is
4lower for individuals with poorer underlying health (and hence with lower life expectancy
as a non smoker) than for individuals with better underlying health.
We also show that there is a strong cohort e®ect. The selection e®ect is important
for the cohorts who started smoking when the information on the e®ect of tobacco on
health was widely publicized, but not so much for previous cohorts. This suggests that
the results obtained in the past by epidemiological studies are not far o® the mark for the
generations considered but that future studies comparing smokers and non smokers will
spuriously reveal a worsening e®ect of tobacco on health if they fail to control for selection.
Finally, combining data on tobacco-free health, survival and income, we evaluate the
amount of foregone earnings from tobacco related death. We evaluate these amounts
for di®erent groups of individuals, according to their sex, education level and underlying
health. We show that foregone earnings depend crucially on the underlying health of the
individual
We begin in Section 2 with a brief history of the tobacco health controversy. The re-
mainder of the section presents a methodological review of the medical, epidemiologic and
economic approaches to the identi¯cation of the e®ect of tobacco on health and mortal-
ity. Section 3 presents our strategy for the identi¯cation of selection into smoking and the
measurement of the e®ect of tobacco on mortality, using a proxy for the individual's under-
lying health. Section 4 presents the data and discusses the construction of the tobacco-free
morbidity indices we use as proxy for underlying health. Section 5 presents evidence of
selection into smoking. Section 6 presents estimates of the e®ect of tobacco on mortality
controlling for selection. Section 7 evaluates the compensation for foregone earnings after
a tobacco related death. Section 8 concludes.
2 A review of di®erent methodological approaches to the
identi¯cation of the e®ect of tobacco on health
The question of the e®ect of tobacco on health has generated passion since the introduction
of tobacco to European societies at the end of the 15th century. Scienti¯c contributions
to this debate have come from the ¯elds of medicine, epidemiology, demography and
economics. Before presenting their respective methodological contributions, we start this
section by a historical review of the tobacco-health controversy, whose interest, if any,
5resides in the account of the evolution of the perception of the e®ect of tobacco on health
since the 15th century, from bene¯cial to detrimental. It is also of interest to note that,
in parallel to this evolution, the understanding that selection into smoking might cause
endogeneity problems in the measurement and interpretation of the observed correlation
was established as early as 1761, but the literature has failed to pursue this agenda.
We then turn to the presentation of recent contributions of medicine, epidemiology and
economics to the measurement of the e®ect of tobacco on health. Finally, we discuss
various methods for controlling for the endogeneity of smoking in mortality.
2.1 A brief history of the tobacco-health controversy
From the moment of its introduction to the Old World in 1492 up to this day, tobacco
has been thought to have e®ects on health, either bene¯cial or detrimental. From the end
of the 15th century until the mid 17th century, tobacco is presented as a panacea, having
curative properties against headaches, fever, rheumatism, nausea, skin complaints. It is
also supposed to be useful in helping childbirth, and remains thought to have properties
against respiratory illnesses until the early 20th century.2
It is di±cult to ¯nd evidence about what led to these surprising views to be held about
tobacco; views that are all the more surprising that evidence against tobacco started to
accumulate very early on. In 1670, the pioneering Dutch anatomist Kerckring describes
his autopsies of heavy smokers: "The tongue of the cadaver is black and gives o® an odor
of poison; the trachea is coated with soot, like a cooking pot; the lungs are dried-out
and almost friable. The corpse gives the overall impression that someone had lit a ¯re
among the organs." A century later, the English physician John Hill publishes what is
probably the ¯rst clinical study of the e®ects of tobacco on health, "Cautions against
the Immoderate Use of Snu®", (Hill (1761)). Hill observes that the consumption of snu®
appears to be associated with cancers of the nose. However, rather remarkably, he also
warns that the observed association might also arise in the absence of a causal e®ect (see
the appendix for an excerpt from the original text). Similar studies are conducted in other
countries throughout the eighteenth and nineteenth centuries, but without causing any
2During the 1665 Great Plague, smoking was made compulsory at Eton in a doomed e®ort to ward o®
infection. Failure to smoke resulted in a whipping. ("The diary of Samuel Pepys" (1633-1703)).
6major stir. However, from the 1920s onwards, attitudes in the scienti¯c community start
to change, as epidemiological studies accumulate which show the existence of a statistical
correlation between cancer and smoking.
In an in°uential article published in Science, Pearl (1938) shows that smokers do not
live as long as non-smokers. By 1944, the American Cancer Society begins to warn about
possible ill e®ects of smoking, although it admits that "no de¯nite evidence exists" linking
smoking and lung cancer. In a 1952 article in the Reader's Digest, Norr (1952) brings
awareness to the larger public of the medical and epidemiological research on tobacco.
Coincidentally or not, after this publication, consumption starts to fall for the ¯rst time
in history, and governments are called upon by public opinion to provide the means of
establishing whether the allegations about the dangers of cigarettes smoking are true.
In the nineteen ¯fties, many governments appoint committees to review the evidence
on smoking and health3. This leads to the publication in the US of the 1964 Report to
the Surgeon General on Smoking and Health which concludes that, regarding age speci¯c
mortality, although there is evidence of a statistical association, "the total number of
excess deaths causally related to cigarette smoking in the U.S. population cannot be
accurately estimated. In view of the continuing and mounting evidence from many sources,
it is the judgment of the Committee that cigarette smoking contributes substantially to
mortality from certain speci¯c diseases and to the overall death rate." (Chapter 4, p 31).
The studies on which the Committee based its conclusions found that the excess death
rate4 is increasing in the quantity of cigarettes smoked; is highest at the earlier ages (40-
50) and declines thereafter. However, later in the report, the strength of the causality
is further quali¯ed as it is concluded regarding smoking that: "This does not rule out
physiological factors, especially in respect to habituation, nor the existence of predisposing
constitutional or hereditary factors" (Chapter 14, p. 377). But whilst allowing for the
possibility of selection into smoking, the Committee is not in a position to conclude as
3The ¯rst task of these committees was to determine what is the nature of evidence which can lead to a
diagnosis of causality. The discussion of the 1964 Report on Smoking and Health to the Surgeon General
on this topic is methodologically still largely in force. We reproduce excerpts from the Report's discussion
on this in the Appendix.
4The excess death rate is the di®erence between actual and expected number of deaths of smokers,
where the latter is constructed from the number of deaths of non smokers, for a speci¯c cause of death,
and sometimes adjusted for age, gender and the quantities of cigarettes smoked.
7to its scale. Indeed, "the available evidence suggests the existence of some morphological
di®erences between smokers and non-smokers, but is too meager to permit a conclusion"
(Chapter 15, p. 387). In the UK, the 1962 Report to the Royal College of Physicians
reached similar conclusions regarding excess death of smokers.
The US, UK and other similar reports have formed the basis for the public health
policies against smoking which have been put in place since the mid nineteen sixties. From
our point of view, these reports are particularly interesting as they do not rule out the
possibility of intrinsic di®erences between smokers and non smokers; intrinsic di®erences
which may lead to selection into smoking and explain part of the observed correlation
between smoking and ill health.
After the publication of these reports, the tobacco health controversy develops into its
current form, with four types of players: the tobacco industry, health associations, gov-
ernment agencies and scientists from the ¯elds of statistics, medicine and epidemiology.
The interests of the ¯rst two groups are clear. The tobacco industry deploys numerous
strategies to avoid its wares being banned, whilst the health associations lobby govern-
ments for regulation of the tobacco industry and the implementation of legal and other
incentives aimed at reducing or outright banning of tobacco consumption. Governments
have to satisfy various objectives, which we will not discuss here. Finally, the scienti¯c
community continues to re¯ne the methods used to explore the links between smoking,
mortality and morbidity.
Among the scienti¯c community, a debate concerning the interpretation of the correla-
tion between tobacco and mortality has involved eminent scientists. The most prominent
opponent of the causal interpretation of the statistical association observed between to-
bacco and mortality was the statistician R.A. Fisher (1957a and b, 1958a, b and c), who
argued that however strong or many they are, measures of statistical association cannot,
by their nature and on their own, support a causal interpretation. Fisher contested the
leap in interpretation from a correlation to a causality and called for further investigation.
He argued that the correlation between mortality, morbidity and smoking could be due
to causality in either direction or to the in°uence of a third factor. Given all that has
been written about Fisher's position, we feel it is important to stress that nowhere in his
writings have we found a defense of the position that tobacco is not harmful to health, but
8rather a position of principle which led him to issue cautionary words against interpreting
any correlation as a causation. The argument of the proponents of the causal interpreta-
tion is essentially that if there is no causal e®ect, the statistical association would not be
either so strong or so universal.
Our view is that the ¯ndings of the medical and epidemiological sciences concerning the
causal e®ect of tobacco regarding a large number of diseases are uncontestable. However,
it remains nonetheless crucial to investigate the question of selection and its consequences
of the measurement of the e®ect of tobacco on health.
We now turn to the recent scienti¯c contributions on the measurement of the e®ect of
tobacco on health. We will argue that the existing medical and epidemiologic approaches
to the identi¯cation of the e®ect of tobacco on health are based upon an extreme as-
sumption, so that the estimates obtained under this assumption do not constitute good
approximations of the e®ect of tobacco on health. Indeed, both the epidemiologic ap-
proach and the medical approach boil down to comparing outcomes for smokers and non
smokers, conditionally on some characteristics, but do not explicitly allow for selection.
2.2 Medical approach
The medical approach is based on either clinical studies, autopsy studies or animal ex-
periments. The method of both clinical studies and autopsies is to observe smokers and
non smokers and compare either health outcomes in the case of clinical studies, or organs,
cells and tissues in the case of autopsies. The conclusion from both type of studies is that
damages to body functions, organs, cells and tissues occur more frequently and severely
in smokers.
For obvious reasons, it is not possible to proceed to random experiments involving
humans to assess the e®ect of smoking on health. However, animal experiments (on mice,
rabbits, dogs and monkeys) have been conducted since the mid 1920s5. The method of
these experiments is to expose animals to tobacco smoke and tars, and to the various
chemical compounds they contain, and to assess their e®ect by comparison with control
groups, as well as perform clinical studies of the treated populations. These experiments
5A very famous series of animal experiments was conducted by Oscar Auerbach, in the 1970s, involving
beagles (Auerbach and Gar¯nkel (1970)).
9lead to the conclusion that "several of the compounds of tobacco are carcinogenic, and
that other substances in tobacco and smoke, though not carcinogenic themselves, promote
cancer production or lower the threshold to a known carcinogen". (1964 Report to the
Surgeon General)
The conclusion from medical studies is that causation is established for animals, and
that the similarity in damage caused by tobacco in animals and damage found in humans
makes a very strong case for causation in humans as well. From our understanding, this
is the closest to causation that medical studies have reached at this point.
2.3 Epidemiologic approach
The epidemiologic approach, based on population studies, is direct and consists in esti-
mating some measure of statistical association between smoking and either mortality or
speci¯c health problems, by comparing outcomes for smokers and non smokers. It is best
described using the framework of binary models, which relate the probability of death
(whether in general or from a speci¯c cause) or the probability of developing a speci¯c








if Xit¯ + ®Si + uit R 0 (1)
where Yit is a binary variable indicating whether individual i is alive at date t (alternatively,
whether individual i has developed a certain disease at date t), Xit is a set of variables
thought to in°uence the probability of death (or of developing the disease), Si is a variable
capturing smoking behavior and uit is a random shock. Depending on the context, the
smoking variable is a variable indicating whether the individual smokes (or has smoked) or
the quantity of cigarettes smoked (in total or habitually).6 In a setup such as equation (1),
the e®ect of tobacco on the health outcome of interest (e.g. mortality), ®; is identi¯ed by
comparing estimated probabilities for smokers and non smokers, conditional on X: This is
only valid to the extent that smokers and non smokers are randomly drawn from the same
6Statistics commonly reported in epidemiology are the excess death of smokers and the mortality ratio
(relative death rates of smokers and non smokers for speci¯c diseases). Both statistics can be obtained
with binary models.
10population in terms of underlying risks. In other words, if smoking is exogenous, the e®ect
of smoking on mortality, ®; is identi¯ed by such a setting. But if mortality depends on a
characteristic "¤
i; unobserved by the researcher (but potentially known to the individual),
such that smoking depends on "¤
i (cov("¤
i;Si) 6= 0); then uit can be written as "¤
i +vit; and
the e®ect of smoking on the outcome Yit is not identi¯ed by equation (1). In the case where
there are unobserved factors which in°uence both smoking and the health outcomes, we
have a classic problem of endogeneity and it is no longer possible to consistently estimate
the e®ect of tobacco on life expectancy without additional information.
Concerns that a limited number of controls in Xi might not capture all the characteris-
tics which in°uence both mortality and smoking has led Sterling and Weinkam (1990) and
Smith and Shipley (1991) to advocate for controlling for as many observable characteris-
tics as possible. The study which controls for the largest set of individual characteristics is
Thun et al. (2000) which controls for education level, race, marital status, diet and alcohol
consumption using a large cohort study from the American Cancer Society prospective
study. They ¯nd that the e®ect of smoking is decreased when conditioning on observed
characteristics, although by a small amount. This and other similar studies show that
smokers are more likely to die from tobacco related diseases than non smokers. What
these studies do not address is the question of the net gain of not smoking in terms of
overall life expectancy, especially if selection is present.
Other studies focus on life expectancy and relate the duration to death to individual
characteristics (Phillips et al. (1996), for instance).
Finally, a considerable number of epidemiological studies compare smokers and non
smokers' outcomes for speci¯c causes of death.7 They have consistently associated smoking
with a variety of diseases, including lung cancer, cancer of the larynx or chronic obstructive
pulmonary diseases. These studies show that reducing tobacco consumption will greatly
reduce death from these causes, which certainly indicates a causal e®ect of tobacco on
health, but does not rule out selection. In other words, the question remains of whether
smokers are more likely to have shorter life expectancy independently from smoking.
Table 1 summarizes some of this research and presents estimates of the impact of
7For instance, a number of studies have used the Framingham study, an important epidemiological
study where the population of a village has been followed for over ¯fty years so as to study morbidity and
mortality among its members.
11tobacco on overall life expectancy. The results indicate that the hazard for dying could
be between two and ¯ve times higher for smokers as compared to non smokers, at all
durations. Sterling and Weinkam (1990) and Smith and Shipley (1991) try to reduce
confounding e®ects by controlling for occupation and ¯nd that the e®ect of smoking is
then reduced. As we can see in Table 1, the range of controls is usually rather limited.
Recent epidemiologic research, also based on population studies, measures the asso-
ciation between genetic make-up and human personality (eg Munafµ o et al. (2003)). It is
found that certain genetic make-ups may be associated with personality traits, which in
turn may in°uence life-style choices such as smoking. We will come back below in section
3 on how these arguments ¯t with our own approach.
2.4 Economic approach
Economists have been interested in smoking as a choice, that is from the angle of ratio-
nality. The question then is how can rational individuals chose to consume a good which
has detrimental e®ects on health? One answer is given in the rational addiction model of
Becker and Murphy (1988). Interestingly, the rational addiction model eschews the ques-
tion of why certain individuals smoke whilst some others do not (the selection question),
but assumes that individuals are born with a level of stock of the addictive good. It is
the interaction of this level of stock, of preference parameters, and of the environment
(prices, income) which determines whether a given individual smokes or not, as the result
of intertemporal optimisation. Because smoking is viewed as a choice, the consumption of
tobacco must respond to standard economic incentives such as income and mainly prices.
The focus of economic studies of tobacco consumption has therefore been to evaluate the
e®ect of changes in prices on consumption (for instance Becker et al. (1994), Chaloupka
(1991) and DeCicca et al. (2001) for measurement of price elasticities of consumption of
tobacco).
To our knowledge, only two papers address the question of selection into smoking,
by Rosenzweig and Schultz (1983), and Evans and Ringel (1999). Both papers study
health outcomes, precisely birth weight of babies, conditional on maternal smoking. Both
allow for endogeneity of smoking and instrument it with prices (or taxes). Evans and
Ringel (1999) ¯nd evidence of endogeneity, hence of selection, whilst the evidence from
12Table 1: Selected Previous Literature, E®ect of Tobacco on Overall Life Expectancy
Authors Data set Method Controls Estimates
Doll et al. (1994) Cohort of 34439 male
British doctors
Comparing hazard rates of
smokers and non smokers
sex, age, occu-
pation
hazard rate 2 to 3
times for smokers
Shaw et al. (2000) Cohort of 34439 male
British doctors
Comparing hazard rates of







Phillips et al. (1996) 7735 middle aged British
men







hazard rate of 2.41
for smokers com-




US National Health Inter-
view and National Mortal-
ity Followback
Comparing life ex-
pectancy of smokers and
non smokers
age, sex Heavy smokers




Smith and Shipley (1991) Whitehall Study of civil
servants aged 40-64, UK
Comparing probability of
death for smokers and non
smokers.
age, occupation Smokers have a two
fold probability of
death.
Hummer et al. (1998) US 1986 National Mortal-
ity Followback Survey
Compare hazard rates of
smoker and non smoker




3Rosenzweig and Schultz (1983) is more mixed. Both use prices as well as a number of
individual and local characteristics as instruments, but they explain little in the variation
in smoking, which might explain why the evidence in terms of endogeneity is mixed.
2.5 Standard approaches to measurement in the presence of endogeneity
To ¯x ideas, let us consider an illustrative version of the endogeneity problem, where indi-
vidual i's age at death, Ti is related to individual characteristics Xi; to smoking behaviour
Si; to "¤
i; an unobserved characteristic of individual i such that cov(Si;"¤
i) 6= 0; and to a
random shock ui:
Ti = ¯Xi + ®Si + "¤
i + ui | {z }
(2)
unobserved
The economic and econometric literatures have considered several possible ways to
deal with endogeneity problems such as outlined above.
A natural solution, as exploited by Rosenzweig and Schultz (1983) and Evans and
Ringel (1999) is to use an instrumental variable approach. One would need to ¯nd an
instrument, correlated with smoking and uncorrelated with the unobservables in equa-
tion (2). This is easier said than done. Any individual characteristic could arguably ¯gure
as a control variable in the regression model (2). Indeed, epidemiologists have argued that
education levels, occupation, income, stress... have a direct e®ect on health and mortality,
whilst economists would argue that they have an e®ect on smoking. Another candidate as
an instrument could be prices, to the extent that they in°uence smoking behavior. 8 How-
ever, in a setting such as equation (2), what is usually thought to in°uence the outcome
is a measure of smoking over the entire life cycle. Using time series variation in prices
would not be satisfactory, as prices would mainly pick up cohort e®ects. Younger cohorts
would have faced higher prices than older ones. However, at any point in time, mortality
is directly explained by cohort e®ects. Finally, spatial variations in prices are not very big
and it has been argued that these are endogenous too.
The announcement of a link between smoking and health in the nineteen sixties could
be seen as an exogenous event, but it would also be linked with the date of birth. Moreover,
8But DeCicca et al. (2001) ¯nd a limited e®ect of prices at least on young individuals.
14the medical literature had started incriminating smoking well before the announcement
of the Surgeon General in the US in 1964 and the Royal College of Physicians in the UK
in 1962, so it might be possible that more educated individuals had already curbed their
smoking behavior.
All in all, it is di±cult to think of a good instrument for smoking patterns over the life
cycle.
A second way, which is often used in economics is to impose more structure on the
problem. We could augment the model with a structural model which would specify how Si
and "¤
i are related. For instance, we could consider a model where the individual maximizes
the expected utility of smoking and of longevity. Such a model would lead to a pair
of behavioural equations, linking smoking behaviour and health behaviour to individual
characteristics, both observed and unobserved, and the environment. Identi¯cation would
then result from the structure of the model. It is worth considering the identi¯cation of
such a model more closely. Suppose that the model restricts smoking to be a®ected only
by one unobserved characteristic "¤
i and by observed characteristics Xi: Si = Si("¤
i;Xi).
Conditional on X; observed smoking patterns would give us a clear signal of the unobserved
characteristic. By inverting the relationship, we could express "¤
i as a function of smoking
and other observable characteristics. We could then go back to equation (2) to get a
consistent estimate of the e®ect of tobacco, as we would now "observe" "¤
i. However,
it is doubtful that, conditional on X; all the heterogeneity in smoking patterns can be
explained by a unique heterogeneity term also a®ecting mortality. Indeed, variation in
smoking could also arise from unobserved taste for tobacco, ´i; so that the model would be
Si = S("¤
i;´i;Xi). In this case, conditional on X; smoking is a blurred signal of di®erences
in both "¤ and ´. We could no longer invert this relationship to extract information on
"¤
i, unless we know the joint distribution of both "¤
i and ´i. As this is rather unlikely, a
structural model would be, in this case, rather useless as an identi¯cation tool.
A third identi¯cation approach would be to use panel data on morbidity, assuming a
¯xed e®ect common to mortality and morbidity and potentially correlated with smoking.
Conditional on functional forms, the ¯xed e®ect can be predicted in a two step procedure
involving the estimation of the morbidity equation in ¯rst di®erences. Unfortunately, this
method is only valid to the extent that one knows the correct speci¯cation which relates
15smoking to morbidity. Any mispeci¯cation would bias the estimate of "¤
i and thus of the
relationship between smoking and mortality.
We will now expose the very simple but novel strategy we follow to control for selection
into smoking and measure the e®ect of tobacco on mortality consistently.
3 Identi¯cation using medical and epidemiological informa-
tion to construct a proxy for tobacco-free morbidity
The previous sections illustrate the di±culty of identifying the e®ect of tobacco on mor-
tality using the tools of epidemiology or of economics alone. We propose an identi¯cation
strategy which borrows from both ¯elds of study, as well as from medicine. Examining
equation (2), we see that there would be no problem of endogeneity if we could observe "¤
i;
that is, if we could observe common in°uences on smoking and mortality, or if we could
observe a proxy for these in°uences. Suppose that "i is a proxy for "¤
i; so that:
"¤
i = ±0 + ±1"i + vi
If ±1; which measures the partial correlation between the proxy and the variable of
interest, is di®erent from zero, then we can obtain consistent estimates of the e®ect of
tobacco on mortality by plugging the proxy "i into the equation of interest, under the
following assumptions:
E[uijXi] = E[uijSi] = E[uij"¤
i] = E[uij"i] = 0
E["¤
ijXi;Si;"i] = E["¤
ij"i] = ±0 + ±1"i
The ¯rst line of assumptions concerns the equation of interest and states that the
errors ui in that equation are uncorrelated with the conditioning variables Xi and Si, the
unobserved variable "¤
i and the proxy "i: The second line of assumptions concerns the
equation for the proxy and states that the errors from that equation, vi; are uncorrelated
with the conditioning variables of the model.
In our context, "¤
i represents unobserved characteristics of the individual which in°u-
ence both mortality and smoking but are not caused by tobacco. Fisher proposed that
these characteristics could be the individual's genotype. The 1964 Report to the Surgeon
16General concludes that it is not possible "to rule out the existence of predisposing consti-
tutional or hereditary factors", which could in°uence both smoking and mortality. Finally,
recent research by Munafo et al. (2003) suggests that there is indeed a link between genes
and behaviour. Our view is that the relevant individual characteristic is probably broader
than the genotype. Indeed, it is possible that not only the genotype, but also randomness
or accidents as well as life-style choices determine our state of health, hence our mortality,
and could in°uence whether we smoke or not (without being caused by smoking). For in-
stance, individuals with the same genotype, such as identical twins do not have the same
phenotype and will not have identical health trajectories. Some of the di®erences will be
determined by "accidents" or random events, some other by choices.
In practice, we do not observe individuals' genotype, or all relevant accidents and life
style choices, but we observe information which may be linked to the genotypes and to
the rest of the elements a®ecting an individuals' fundamental health. Indeed, we observe
individuals' health, and we propose to use part of the information contained in the variation
in health between individuals as a proxy for "¤
i. More precisely, we use variation in health
which is not caused by smoking. Suppose we can construct an indicator of morbidity
that is correlated with mortality but not caused by smoking. This morbidity indicator
will constitute a valid proxy for "¤
i if it satis¯es the conditions detailed above. We need
some characteristic of the individual which causes mortality but is not caused by smoking.
Whilst there is disagreement among the medical and epidemiological communities about
the extent of the detrimental e®ect of tobacco on health, there is agreement on which
illnesses are caused and, to some extent, on which illnesses are not caused by tobacco.
Illnesses can therefore be organized into three categories: illnesses that are caused by
tobacco (e.g. lung cancer, chronic obstructive pulmonary diseases), illnesses that may be
caused by tobacco but may also occur independently from it (cardio vascular diseases,
stomach ulcer, type II diabetes...), and ¯nally illnesses that occur independently from the
individual's consumption of tobacco (congenital diseases, urinary infections, back pain...).
Using medical and epidemiological information, we can determine, for any given medi-
cal condition, which category it falls in. On the basis of this information, we can construct
an index of the part of morbidity which is independent from tobacco. The part of an indi-
vidual's morbidity which occurs independently from tobacco is what we use as a proxy for
17"¤
i: It is a valid proxy if it is correlated with life expectancy, but not caused by smoking.
Note that out identi¯cation strategy is valid if the development of illnesses that are not
caused by tobacco is the same for smokers and non smokers.
A similar methodology is often used in labor economics: proxies for ability such as test
scores or IQ scores are often used for ability in wage equations.
We now turn to the presentation of our data set and on the construction of the tobacco-
free morbidity index we use as a proxy.
4 The Data
We use data from the Swedish Survey of Living Condition, \UndersÄ okningen av Lev-
nadsFÄ orhº allanden" (ULF). Approximately 6000 individuals, representative of the whole
population, are surveyed each year. The ULF reports information on quantities smoked,
smoking history, education, occupation, family composition, income as well as many health
measures. The data set has been merged with the Record of Deaths in 1999, so that we
observe whether a given individual is alive up to the end of 1998, and if not, the date and
cause of death. We use the 1980-81, 1988-89 and 1996-97 cross sections, as in these years
the survey has a special section on health. In total, the data set includes 38986 individuals
and we observe 6593 deaths. Within this large dataset, Statistic Sweden has constructed
a smaller panel data set which follows individuals for two or three interviews (about 5000
individuals which we use for robustness checks).
Table 2 displays the characteristics of the data set and of the Swedish population.
About half of the individuals in the sample are or have been smoker. Men are more
likely to be or to have been smokers. The smoking prevalence is around 25%, with similar
proportion for men and women. However, at young ages (under age 30), women are more
likely to be smoking. The number of cigarettes consumed per day is low compared to
other countries (15.5 in the UK, 24 in the US 9).
Regarding smoking behaviour, we observe the quantities smoked, the duration of the
smoking habit, and for some individuals the age at which they start smoking. However,
individuals are not asked complete histories, but rather they answer questions from which it
is possible to construct histories under the assumption that they have smoked continuously
9Sources, UK: British Household Panel Survey, 1995, US: World Health Organization, 2000.
18since they started smoking (until they have quit if they have). This is a drawback of this
data, in that it does not allow the analysis of multiple smoking spells.
The survey records traditional individual outcomes and characteristics, such as ed-
ucation, occupation, family composition, or income. It is important to note that other
risk taking behaviour, such as consumption of alcohol or of snuss (a variety of chewing
tobacco) are recorded, as well as risky occupations.
We ¯rst present the morbidity information content of the data, before turning to the
construction of the tobacco-free health scores.
4.1 Morbidity
The data set contains an extensive set of health questions, including self-assessed health,
body mass index, hospital visits, ability to run, walk or climb stairs. The survey also
asked extensive information on any speci¯c health problems which were coded with the
International Classi¯cation of Diseases (ICD 8 and 9) by nurses. Each individual can
report up to six di®erent health problems. In addition to all this information, we also
have information on the severity of the disease (coded in 4 modalities) and an indication
on when this problem started, so we can distinguish acute from chronic problems. These
health problems range from relatively minor problems such as back pain or skin problems
to life threatening such as speci¯c cancers, ischemic heart problems or diabetes. In total,
there are 155 variables to describe the health of an individual.
To summarize the information contained in this large number of variables, we construct
a general morbidity index, using principal components analysis. We use indicators of
general health, of perceived state of health relative to one's cohort, an indicator of the
existence of long term illness, indicators for the range of body mass index in 3 modalities,
indicators of whether the individual can run, walk up a °ight of stairs, and board a bus.
We also use information on the presence of heart conditions, of insomnia, anxiety, of taking
antibiotics, of coughing, having a skin condition, having been to the hospital in the past
two weeks, of being diabetic, having a neoplasm, hypertension, asthma, ischemic problems,
cerebral problems, problems with arteries, veins, pulmonary obstructive diseases, stomach
illness, hernia, cirrhoses, etc...
The morbidity index is increasing with age. Its variance is also increasing with age until
19around 85 years old, after which it decreases. However, there is considerable heterogeneity
even at young ages. 10 The index is evidently correlated with smoking as we have included
all observed conditions, some of them being directly caused by smoking. We turn next to
the construction of several tobacco-free morbidity scores, which will be used to proxy for
the omitted common determinant of health and smoking.
4.2 Tobacco-Free Morbidity Scores
As described in section (3), the identi¯cation strategy we employ combines simple econo-
metric techniques with medical and epidemiological knowledge. The latter is used to
isolate medical conditions of which it is known that they are not caused by tobacco. Our
proxy for tobacco-free morbidity will be constructed using variability in diseases that are
not caused by tobacco. To construct the tobacco-free morbidity index, we disregard a
number of diseases which have been linked to tobacco consumption. These include a num-
ber of cancers (eg cancers of the lung or of the oral cavity), all cardiovascular diseases
(including ischemic heart disease and hypertension), respiratory diseases and diseases of
the oesophagus (which includes stomach ulcers). We also disregard general health mea-
sures such as self-assessed health, body mass index and a number of variables describing
the ability to walk or climb stairs, which could be caused by smoking.
To establish whether a disease should be included or excluded from the proxy, for
each morbidity indicator in our data set, we checked in the medical and epidemiological
literature whether the disease has been linked to smoking. While it is easy to exclude well
researched diseases such as cancers and cardiovascular problems, it is more di±cult to
classify more particular ones. For some diseases, it may be that no link is known because
the medical profession has not yet established a link between smoking and morbidity or
mortality. Furthermore, drawing the line between diseases is also made more di±cult
given the frequent confusion in the literature between correlation and causation. These
reasons could lead us to either include or exclude too many diseases from the tobacco-free
morbidity score. The latter case would result in a loss of power for the proxy. With fewer
10From the panel dimension, health appears to be very persistent through time. Individuals in poorer
health in one period are very likely to be in poor health eight years later. In fact, health appears to be a
random walk at the individual level.
20diseases, the health score is less likely to contain any tobacco related diseases, but it will
perform more poorly as a proxy for the unobserved general health. The former case, where
diseases caused by tobacco are included in the tobacco free morbidity scores, would lead
to there remaining some bias in the estimated e®ect of tobacco on mortality. There is
therefore a trade-o® between a potential bias due to the de¯nition of our health score and
its power.
In the absence of an entirely clear line of demarcation between types of diseases, we
construct three di®erent tobacco-free morbidity scores, each with fewer and fewer diseases
included. The ¯rst score contains 29 health conditions, the second 19 and the third score
contains only one health condition, namely adult height adjusted for sex. A list of the
morbidity indicators used to construct the three scores are listed in Table 3. We believe
that by using three scores, the last of which is obviously not caused by tobacco 11, we are
able to de°ect the criticism that our results are due to remaining endogeneity.
We construct the three health scores, (labelled as Score 1, 2 and 3) by using the
factor analysis discussed above and selecting only the relevant diseases. To check whether
the health scores are correlated with subsequent mortality, we estimate the e®ect of the
health scores on the duration to death using a Cox proportional hazard model. We rank
the individual's tobacco-free morbidity within age groups (using 10 years bands) and we
classify individuals who are in the lowest 25% quantile as being in good health. Similarly,
we classify individuals in the upper 25% quantile as being in poor health. The hazard
ratio for poor health compared to good health is equal to 1.24, [1.15, 1.33] for Score 1,
1.16 [1.08, 1.25] for Score 2 and 1.09 [1.01, 1.17] for Score 3 (95% con¯dence intervals in
brackets). All of the three health scores predict mortality, although not surprisingly, the
e®ect is stronger the more health conditions are included.
Without loss of generality, each of the health scores have been normalized between 0
(for the individual with best health) and 100 (worst health).12
11While maternal smoking leads to low birth weight, the rate of growth of these children in subsequent
years compensates the initial handicap, so that, at puberty, there is no impact of maternal smoking, see
for instance Ong et al. (2002). From a purely technical point of view, note that if low birth weight leads
to shorter adult height, height could nonetheless be used as a proxy for "
¤
i provided it is not caused by the
individual's smoking.
12Regarding Score 3, height adjusted for sex, it means that high values of the score correspond to short
height (adjusted for sex) and vice-versa.
214.3 Other Risky Behaviors
Health can be a®ected by risky behaviors other than smoking. For instance, smokers are
also more prone to be heavy drinkers or to drive without a seat-belt (Hersch (1996)).
Should our proxy for the individual's underlying health capture the e®ects on health of
other risky behaviors? It depends on the question we want to address, whether we want
to evaluate the medical e®ect of an individual's own tobacco consumption on her health
or the total e®ect on health of a smoking ban. In the ¯rst case, we want to compare the
health of a smoker to the health of a non smoker with similar characteristics, including
other risky behaviors such as drinking. The presence of morbidity indicators caused by
other risky behavior is therefore not a problem.
In the latter case, the use of morbidity indicators related to other risky behavior
matters for the interpretation of the results. The interpretation depends on whether
smoking and other risky behaviors are substitutes or complements. The literature on
this subject gives mixed results. 13 Eradicating tobacco may lead the individual to either
increase or decrease other risky behavior, and this may have an impact on the individual's
health. If the tobacco-free morbidity scores are in°uenced by, say, drinking, we would
like to contrast the health of a smoker to that of a non-smoker who either drinks more
(substitute) or less (complement).
Given the lack of clear results in the literature, we adopt two strategies. First, we
have tried to disregard morbidity indices which are too obviously related to other risky
behavior (such as cirrhosis and diseases of the liver). Our last health score is certainly
immune from any e®ect of other risky behavior. Second, given that we have information
on other risky behavior in our data set, we also use this information as control variables
in our regressions.
4.4 Comparison with Previous Studies
Before turning to the measure of the e®ect of tobacco on mortality correcting for selection,
we replicate, on the Swedish data, the studies detailed in Table A above, so as to have
13Chaloupka (1999) ¯nds that smoking and marijuana appears to be complements. Dee (1999) ¯nds that
smoking and drinking appears to be complements, while Decker and Schwartz (2000)) ¯nd that smoking
and drinking are substitutes.
22some point of comparison. We ¯nd that the hazard ratio, when controlling for age, sex,
marital status, BMI, and alcohol consumption is 1.3, to compare with a hazard ratio of
2.4 in the study of Phillips, Wannamethee, Walker, Thomson, Davey-Smith (1996). Our
results show that the estimated e®ect of tobacco is consistently smaller in the Swedish
data than in the epidemiological studies we use as benchmark. We believe the hazard rate
for smokers is much lower for the Swedish data because average quantities smoked are
much lower in Sweden than in the US or in the UK.
We will now use the tobacco-free morbidity scores to establish that there is selection
into smoking, in the sense that smokers are not drawn randomly from the distribution of
tobacco-free morbidity scores. We will then turn to measuring the e®ect of tobacco on
mortality controlling for selection.
5 Selection into smoking
We will now proceed to show that there is indeed selection into smoking in that individuals
with worse tobacco-free morbidity tend to be associated more with smoking. To do this, if
it is the case that there is no causal link from smoking to the tobacco-free morbidity status
as measured by the three scores, it su±ces to document the existence of a correlation
between the tobacco-free morbidity scores and smoking. We will then discuss how the
pattern of evidence in the data goes against the hypothesis that the tobacco free morbidity
scores are contaminated by diseases caused by tobacco.
Smoking is captured in three dimensions: whether an individual is a smoker or not,
the quantities smoked and ¯nally the duration of the smoking habit. We will show that
there is selection in these three dimensions, starting with whether individuals are or have
ever been smokers. We will also provide robustness checks of our identifying assumption.
5.1 Selection into smoking status
The ¯rst piece of evidence we present, in Figure 1, is the relationship between smoking and
the tobacco-free morbidity scores. Each curve presents the average (by age) of tobacco-free
morbidity as a function of age respectively for smokers (current and formers) and for non
smokers.
23The values taken by the morbidity scores are increasing with age, indicating a wors-
ening of tobacco-free morbidity with age, for both smokers and non smokers. Recall that
the third morbidity index (Score 3) is the opposite of height adjusted for gender, so the
fact that it increases with age merely indicates that younger generations are taller. As the
other two morbidity scores include height for sex, the increases in the ¯rst two scores with
age are partly due to di®erences in height across generations. However, the increase in
their values with age also re°ects the fact that, independently from smoking, health tends
to deteriorate with age.
Turning now to the correlation between smoking and tobacco-free morbidity, the ¯rst
two graphs illustrate that, at all ages, smokers (current and former) are on average in
poorer health than individuals who have never smoked. However, for Score 1 and Score 2,
at around age 50, the di®erence in morbidity vanishes and smokers and non smokers appear
to have essentially the same health. Note that a decreasing number of observations at later
ages means that the con¯dence bands (not shown) get larger after age 60 and probably
explains the pattern for Score 3.
These results, which show a di®erence in terms of tobacco-free morbidity between
smokers and non smokers, are crude averages which do not control for any other charac-
teristics. We will present results obtained controlling for observed characteristics below,
but ¯rst we discuss why the di®erence in tobacco-free morbidity between smokers and non
smokers becomes less signi¯cant at older ages.
To interpret the fact that the tobacco-free morbidity scores of smokers and non-smokers
appear to converge at older ages, we need to separate the age e®ect from the cohort e®ect.
To this end, we use the repeated cross section feature of our data set. To be able to compare
the health of individuals at di®erent ages, we consider their health quantile within an age
group, rather than their health score directly, as health is age dependent (we use 10 years
age bands). Next, we compute the average quantile in the general health distribution of
a smoker by year of birth, from 1904 to 1977. Under the assumption that there is no
selection on health, the median health quantile of smokers and non smokers should be
equal to 0.5.
Figure 2 displays the median tobacco-free health quantile of smokers as a function of
year of birth. Note that we have three cross sections, so we observe a same cohort up to
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25three times at di®erent ages.
The further from the 0.5 line is the average quantile for health for smokers, the more
selection there is. As apparent from the ¯gure, there is some evidence that smokers
born around 1900 were in better health than non smokers. This could either be a healthy
survivor e®ect or the fact that in the beginning of last century, mostly a²uent and well-o®
people (who are also in better health) smoked. This e®ect becomes negligible between 1910
and 1940. From 1940 onwards, smokers are increasingly coming from a population with
poorer health. 14 Among individuals born towards the end of the period of observation, the
median smoker has a health in the 54% quantile of the health distribution. This pattern
seems to indicate that the selection based on health started when information on the
health e®ect of cigarettes was released. Those with the best health may have decided that
smoking was not worth the risk, so that prevalence among this group decreases through
time. 15
Next, we control for a number of observed factors. Table 4, Panel A presents the odds
ratio corresponding to the probability of being a smoker (current or former), controlling
for age, sex, education level, interview year e®ects, risk taking behaviors (on the job
risk, snus consumption, alcohol consumption) and tobacco-free morbidity. The odds-ratio
are calculated for the 25% of individuals with the best tobacco-free morbidity relative
to the 25% of individuals with the worst tobacco-free morbidity (where the ranking was
de¯ned within age groups as above). We ¯nd essentially the same results as in Figure 1.
Controlling for individual characteristics, at older ages, tobacco-free morbidity does not
appear to predict the smoking status (the odds ratio is not di®erent from 1 for a sub-sample
of individuals aged more than sixty). However, when we look at younger individuals, the
e®ect of being in poor health (in terms of tobacco-free morbidity) becomes signi¯cant and
is quite strong. When we consider Score 1, and selecting individuals aged less than 25, an
individual with poor tobacco-free morbidity is 1.36 times more likely to be a smoker than
if he were in good health (in terms of tobacco free morbidity), everything else being equal.
We get comparable e®ects when we use the second morbidity index (Score 2). For Score
3, the magnitude of the e®ect is reduced and the standard errors are larger, but the e®ect
14This e®ect is clearly apparent for both Score 1 and Score 2 and to a lesser extent for Score 3.
15Viscusi (1990), Kenkel (1991) and Antonanzas et al. (2000) show that smokers are aware of the risks
associated with smoking, and sometimes over-estimate the risks.
26Figure 2: Average Quantiles of Health for Smokers (Current and Former)























































27for the youngest individuals is still signi¯cant at the 5% level. This is somewhat expected
as Score 3 contains much less information on the \health type" of an individual than the
¯rst two measures.
Overall, this provides evidence that there is a signi¯cant correlation between smoking
and tobacco-free morbidity, except for older individuals, even when one controls for other
risky behaviour. The fact that there is a correlation could be evidence of selection where
individuals in worse health are more likely to engage in smoking, or it could be evidence
that our health scores are not tobacco-free as we claimed initially. If we have included in
the health score a morbidity variable which is in fact caused by tobacco, we would evidently
¯nd that smokers are more likely to be in worse health than non smokers. However, the
pattern of the e®ect does not appear to be consistent with this latter explanation. If
the tobacco-free morbidity indices did contain some illness related to tobacco, one would
expect that the e®ect of health on smoking would be much stronger as age increases. Older
smokers would be more likely to develop tobacco-related diseases as they have been exposed
to tobacco for a longer period. Not only do we not see this, but we ¯nd the opposite, a
smaller correlation between smoking and the health indices for older individuals. Moreover,
we ¯nd a correlation between tobacco-free health scores and smoking at young ages. If
this were due to causal e®ects of smoking on health as encapsulated by our scores, it
would mean that the diseases caused by tobacco which we would be capturing would
have to develop fast enough to a®ect the youngest age group in a signi¯cant way (note
that the median age in that group is only 20 years.) The idea that tobacco would a®ect
health so rapidly goes against all received wisdom about the e®ect of tobacco on health,
so that we believe it can be ruled out. We will provide further evidence that the tobacco-
free morbidity scores do not appear to be contaminated by tobacco-related diseases in
section 5.4. We interpret this as evidence that the tobacco free morbidity scores are
indeed free of causal e®ect from tobacco. We also see the fact that older individuals are
not a®ected as indicating a change in selection into smoking through the twentieth century.
We believe this evidence is very di±cult to explain by means other than selection and
moreover by an increasing selection for younger cohorts.
285.2 Selection into smoking intensity
We next look at the intensity of smoking for current smokers and its relation to the tobacco-
free morbidity scores. We regress an indicator for heavy smoking (more than a pack a
day), conditional on smoking, on tobacco-free morbidity indicators and the same controls
as in the previous section. The results are presented in Table 4, Panel B. The coe±cients
reported show odds-ratio for heavy smoking for the poor health group compared to the
good health group. We ¯nd signi¯cant e®ects for individuals between 25 and 50, using the
¯rst two morbidity scores. Poor health individuals are about 1.3 times more likely to be
heavy smokers.
At a young age, the number of cigarettes smoked may not be linked to the underlying
morbidity of the individual, but healthier types of individuals reduce the quantities they
are smoking as they age.
Panel C provides the results for the probability of smoking more than a pack a day,
unconditional on smoking, for individuals between 25 and 50. These odds-ratio combines
both the selection on the extensive and the intensive margin. For the ¯rst two health
scores, the results are similar. Overall, a poor health individual is 1.8 times more likely
to be a heavy smoker, compared to a good health individual. The e®ect is smaller when
we use Score 3, at around 1.3, and is signi¯cant at the 10% con¯dence level.
5.3 Selection into smoking duration
We now turn to the duration of the smoking habit. There are two dimensions, the age
at which individuals start smoking and the overall duration. Table 4, Panel D presents
the relative e®ect of poor compared to good tobacco-free morbidity on the probability
of starting smoking before age 15 (strictly). The table presents the odds-ratio, obtained
from a logistic regression of the probability of starting smoking before age 15, controlling
for sex, other risk taking behaviors, interview year dummies and age. Using the ¯rst two
scores, poor health individuals are about 1.5 times more likely to start smoking at an
early age. For Score 3, this ¯gure is about 1.2. In this regression, we have restricted the
sample to young individuals who are observed smoking in order to be able to compute an
accurate measure of the starting age.
Based on the information on the duration of the smoking habit, we estimate a Cox
29proportional hazard duration model to quitting. We include as regressors a list of individ-
ual characteristics (sex, education, occupation, interview year e®ects, risk taking behavior
other than smoking) as well as an indicator for the tobacco-free health group. The regres-
sion is strati¯ed by sex, education level and occupation.
The results are presented in the form of hazard ratios in Table 4, Panel E. In all cases,
the poor health individuals are less likely to give up smoking. The magnitude of the e®ect
is about 10% and remarkably consistent across health measures.
Interestingly, the epidemiological literature often ¯nds signi¯cant bene¯cial e®ects of
quitting smoking (see for instance Doll and Hill (1956), Hammond and Horn (1958), Doll
and Peto (1976), Kawachi et al. (1993), Kawachi et al. (1997), Hrubec and McLaughlin
(1997)). The results presented above do not dispute the fact that quitting may result
in lower rates of lung cancers or any other tobacco related diseases. But they indicate
that the overall bene¯t of quitting smoking is probably somewhat lower than what has
been indicated in the literature, given that these studies do not control for the underlying
health of the individuals.
5.4 Further Robustness Check: Changes in tobacco-free morbidity
Finally, to provide a further robustness check of our methodology, we investigate the
extent to which the changes in the tobacco-free morbidity scores are related to either
smoking status, quantities or durations. Indeed, our identi¯cation strategy requires that
the evolution of tobacco-free health be independent from smoking. If we found that the
value of the indices increases with quantities or duration, one would be suspicious that one
of the morbidity indicators used to construct the health scores might be causally related
to tobacco. We therefore check that this is not the case. To this end, we use the panel
data contained within our larger repeated cross-section data. We regress the change in
the tobacco-free morbidity scores (eight years apart) on smoking status, quantities smoked
and duration. The results are displayed in Table 5. We cannot use the third health score
(adjusted adult height) as this is a ¯xed characteristic of the individual. For the ¯rst two
health scores, we cannot ¯nd any evidence that the health of smokers deteriorates faster
than for those who have never smoked, even for individuals older than age 40. We ¯nd
similar evidence when we investigate the role of smoking intensity. Finally, the duration
30of the habit appears to be uncorrelated with changes in health scores. We conclude from
these results that our morbidity indicators are picking up health problems not related to
tobacco. The di®erence in tobacco-free health levels between smokers and non smokers
are therefore likely to be the consequence of selection.
6 The e®ect of tobacco on mortality
In this section, we evaluate the e®ect of smoking on mortality controlling for selection.
We have shown in the previous section that smokers are more likely to be drawn from a
population with worse tobacco-free health. Given that health is correlated with subsequent
mortality, the fact that there is selection implies that comparing the life expectancy of
smokers to that of non smokers will not give the correct e®ect of smoking on mortality. This
is true even when conditioning on usual observed characteristics such as sex, education
levels and even other risk taking behaviors. The correct way to proceed is to compare
the life expectancy of individuals, smokers and non smokers, who would have the same
life expectancy if they did not smoke. This is what we propose to do using the tobacco-
free morbidity scores, which are constructed to capture the fundamental health of the
individual, independently from smoking.
However, before we do this, we have to recall that we have also shown that selection is
mostly present for younger generations who have been aware of the risks they faced when
choosing to smoke and started in the nineteen ¯fties and nineteen sixties. This has two
important consequences for the measurement of the e®ect of tobacco on health. Firstly,
note that studies which investigate the e®ect of smoking on mortality rely mainly on elderly
individuals for identi¯cation (as individuals who die are essentially drawn from the eldest
cohorts of both smokers and non smokers), and we have seen that this is a population for
which there is a minimal selection bias. This means that previous epidemiology studies
probably do not miss much by ignoring selection on the basis of underlying health. The
second consequence is that, as time passes, the gain from preventing a smoker from smoking
will decrease. With time, epidemiological studies will conclude to a worsening e®ect of
tobacco on health, when what is happening is increased selection. Indeed, from 2010-2020
onwards, the generations born in the nineteen ¯fties and nineteen sixties will start to
face an increased likelihood of death and studies that use data on mortality and smoking
31alone will spuriously reveal a worsening e®ect of tobacco, as these studies will increasingly
compare poor health smokers to non smokers in better health.
We can easily document this using our data. We estimate a model of duration to
death, where we condition for a set of individual characteristics, smoking and non tobacco-
related morbidity. The results are displayed in Table 6. We obtained them from a Cox
proportional model, strati¯ed by sex and education level, controlling or not for tobacco-
free health. The ¯rst line of the table shows the hazard ratio for smokers as compared
to non smokers (1.31) and for heavy smokers as compared to non smokers (1.85). The
second line of the table shows the same hazard ratio, when stratifying on tobacco-free
health as well. The values of the hazard ratio do not change, respectively at 1.30 and 1.83.
As expected, given that the individuals who are observed dying are largely drawn from
the older cohorts for whom there is little or no selection into smoking, the hazard ratio is
unchanged when we control for health. We are not in a position to document that there is
a selection on underlying health for the younger generations using the model of duration
to death, as there are too few deaths among the cohorts concerned at this point. However,
we have already documented above that there is selection for these cohorts, which makes
the point.
These remarks are important as they determine how we can, using data where essen-
tially those who die did not select into smoking, obtain a consistent measure of the e®ect
of tobacco on mortality for selected groups. Indeed, a strati¯ed model such as estimated
corresponds to the assumption that the baseline hazard is unique to each stratum, but
that otherwise, di®erent observations have identical coe±cients:
¸(ti) = ¸0k(ti)exp(Xi¯)
for observation i in strata k: It is possible that such a model is too constraining for the
data, and that with the emergence of selection and the change in the composition of
the smoking population, it is necessary to allow for both the baseline hazard and other
coe±cients to di®er between types of individuals. We estimate a model where we allow the
baseline hazard to di®er between strata de¯ned on sex and education and other coe±cients
to di®er between health groups de¯ned as before. Table 5, lines 3 and 4 show the hazard
ratio for poor health smokers compared to poor health non smokers, which show that at
each duration, the former have a 1.25 higher chance of dying than the latter (for heavy
32smokers, the ¯gure is almost 1.6). Turning to good health smokers, the hazard ratio is
1.45 for smokers and 1.84 for heavy smokers. Finally, we estimate a last model, where we
only stratify on sex and allow all coe±cients to di®er by health groups and education level.
The results are not very di®erent from those obtained above. Note that here, we are able
to capture di®erences in the parameters for good and poor health individuals because we
are exploiting data from all age groups, so that even though there are few deaths among
the younger cohorts, and little selection among the older cohorts, put together, there is
enough variation that di®erences can be made apparent using a Cox proportional hazard
model.
Figure 3 plots the hazard ratio of death as a function of the quantile of tobacco free
health. The ¯rst panel displays the hazard for smokers (current and former) compared to
never smokers. The hazard ratio of death is equal to 1.5 for the healthiest individuals and
decreases at about 1.2 for poor health individuals. The second panel displays the hazard
ratio for heavy smokers (more than 20 cigarettes per day) compared to never smokers. The
hazard ratio varies between 3 for the healthiest to about 1.5 for those with the poorest
health.
Figure 3: Heterogeneity in the E®ect of Tobacco on Mortality
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It is interesting to convert the numbers obtained in terms of hazard ratio into numbers
33of years of life lost. Poor health smokers lose on average 3 years, as compared to poor
health non smokers, and 5.5 years if they are poor health heavy smokers. For individuals
whose health is good independently from smoking, the losses are greater: 4.5 years from
being a smoker, and 6.8 from being a heavy smoker. The loss from smoking is greater for
individuals whose life expectancy is greater if they do not smoke. Note that this result
is not an artefact of our data or our method. Indeed, recall that the 1964 Report to the
Surgeon General on Tobacco and Health collates results from a large number of studies
which report that the excess death rate of smokers is highest at younger ages (around 40
to 50 years of age). This is in agreement with the pattern we ¯nd where the loss is greater
for long life expectancy individuals than for short life expectancy individuals. Individuals
with a high "¤
i (and thus with a long life expectancy) might loose more from smoking as
they may die prematurely from, say, lung cancer. On the other hand, those with a short
life expectancy even as a non smoker may loose less from smoking. If this is the case, it
means that the selection e®ect will have some consequences on policies which try to reduce
smoking prevalence. The e®ect of tobacco on mortality estimated on a population born
at the beginning of the twentieth century will be misleading to predict the bene¯t of not
smoking for a younger population. The real gain from not smoking will be declining over
time due to the increased selection.
7 Compensating Foregone Earnings due to Tobacco Related
Deaths
The previous sections showed the importance of health selection into smoking and its im-
plication for the evaluation of the e®ect of tobacco on health and mortality. One cannot
easily compare smokers and non smokers, even when controlling for observed character-
istics such as gender, education or occupation. We investigate here the impact of health
selection on monetary compensations as a result of a tobacco related death.
We calculate the amount of foregone earnings as a result of a premature death. We do
not attempt to evaluate the general value of life or the willingness to pay for an extended
life-time. We combine information on survival and earnings and we compare smokers and
non smokers, controlling for some observed characteristics such as gender and education
level and, more importantly, for their underlying health as captured by our tobacco-free
34morbidity indicators.
We assume that we can approximate the survival and earnings patterns of smokers by
the survival and earnings patterns of non smokers with similar characteristics if we include
their underlying health. We calculate the net present value of earnings, weighted by the
probability of survival for non smokers at all ages between 20 and 100. We interpret this
amount as foregone earnings for smokers as a result of an early death.
For any possible age at death, we calculate the amount of compensation equal to
the sum of future forgone earnings, weighted by the age and group speci¯c probability
of survival. We split the population into 18 separate group according to their gender,
education level (in three modalities) and underlying health as measured by our tobacco-
free morbidity Score 1 (in three modalities).
Let t be the age at death. Let yi;t+l represent the average income of an individual of
age t + l who is alive and in group i = 1;:::;18. Let sit+l be the conditional survival
probability from age t + l to t + l + 1 of an individual in group i who has never smoked.




(1 + r)¡lyi;t+lsi;t+l (3)
where r is the real interest rate. All income ¯gures have been converted into US dollars, as
of year 2000 for ease of reading. We ¯xed the interest rate to 3 percent annually. Figure 4
plots the envelope of compensations across all groups and for all possible age at death
between 20 and 100. The amount of compensation is overall decreasing with age. It varies
from 0.8 million dollars to almost zero at the oldest ages. Moreover, at any given age at
death, there is considerable heterogeneity in the amount of compensations required. This
is due to variability across groups in survival probabilities and in average level of earnings.
Table 7 displays the compensation ¯gures by sex, education level and tobacco-free
health groups at a hypothetical age at death of 55. All ¯gures are expressed in millions
of US dollars. We also provide in brackets the compensation based on the 20% and 80%
quantiles of life cycle-earnings. For individuals with a low education, the ¯gure is at
about 0.1 million US dollars. This number is fairly similar for men and women and vary
slightly with the underlying health of the individual. For medium educated individuals,
and especially for men, the underlying health matters, and the compensations varies from
35Figure 4: Average Compensation for Loss of Income As a Function of Age at Death,
Millions of US Dollars























































360.1 to about 0.2 million dollars. There is also a gender di®erence, re°ecting the fact that
men earn on average higher wages.
The highest compensation ¯gure is for men with a high education and in good (tobacco-
free) health. This is due to the fact that this group has the highest earnings and a low
probability of death for non smokers. Going from the lowest health group to the highest
doubles the average compensation estimate, from 0.14 to about 0.27 million dollars.
Conditioning on the tobacco-free health measures does matter quite a lot for individuals
with a high or medium education. This is due to the heterogenous e®ect of tobacco on life
expectancy documented in section 6. The trend in selection means that compensations for
forgone earnings should decline with time and perhaps take into account the heterogeneity
in potential life expectancy.
8 Conclusion
This paper considers the e®ect of tobacco on mortality allowing smoking to be endogenous.
If smoking and underlying health are correlated, most estimates found in the literature are
biased. We discuss the identi¯cation of the e®ect of tobacco allowing for endogeneity and
we propose a way to get a consistent estimate of this e®ect under weaker assumptions than
are usually made in this literature. Our approach is to use a proxy for the unobservable
element which causes the endogeneity bias. We use extensive data on date of death and
morbidity, together with a model of duration to death to obtain estimates of the e®ect of
tobacco on health which correct for selection. Our main ¯ndings are:
² There is evidence of selection into smoking. Everything else being equal, smokers
come from a population in poorer health independently from smoking than non
smokers. In other words, individuals with shorter potential life expectancy smoke
more than individuals with longer potential life expectancy.
² The e®ect of smoking on life expectancy di®ers by types of individuals, with indi-
viduals with longer potential expectancy having more to loose in terms of years of
life by smoking. The variation in terms of years of life lost is quite important, going
from three to almost eight years.
37² This implies that the gains from reducing smoking are not as large as they would
be thought to be without accounting for selection into smoking, given that health
in°uences potential life expectancy. Moreover, because of the increased selection of
smokers, the gains will decrease over time.
² There is a strong cohort e®ect. The selection e®ect is important for the cohorts who
started smoking when the information on the e®ect of tobacco on health was widely
publicized, but not so much for previous cohorts.
² The existence of the cohort e®ect means that the results obtained in the past by
epidemiological studies are not far o® the mark for the generations considered but
that future studies comparing smokers and non smokers will spuriously reveal a
worsening e®ect of tobacco on health if they fail to control for selection.
² Finally, combining data on tobacco-free health, survival and income, we evaluate the
amount of foregone earnings from tobacco related death and we show that foregone
earnings depend crucially on the underlying health of the individual.
A number of factors could explain a correlation between smoking choices and mortality,
above the sheer medical e®ect. For instance, both mortality and smoking decision could be
in°uenced by other factors such as stress, neighborhood e®ects or social norms. It is also
possible that smoking and mortality are linked through a trade-o® between smoking and
longer life expectancy. In this trade-o®, individuals with longer potential life expectancy
might have incentives to smoke less. Finally, smokers and non smokers may have di®erent
discount factors. Whatever the reasons, it is important to try to separate out the true
e®ect of tobacco from the selection e®ect, which is what we do here. In a companion
paper, Adda and Lechene (2004), we examine the question of the structural mechanisms
which can lead to the observed evidence.
38A Appendix
A.1 Excerpt from "Cautions Against the Immoderate Use of Snu® and
the E®ects It Must Produce When This Way Taken into the Body",
John Hill, 1761.
Excerpt from the ¯rst clinical study of the e®ect of tobacco on health, "Cautions Against the
Immoderate Use of Snu® and the E®ects It Must Produce When This Way Taken into the Body",
by John Hill, 1761, London: R. Baldwin & J. Jackson: "Whether or not polypuses, which attend
Snu®-takers, are absolutely caused by that custom; or whether the principles of the disorder were
there before, and Snu® only irritated the parts, and hastened the mischief, I shall not pretend to
determine: but even supposing the latter only to be the case, the damage is certainly more than
the indulgence is worth. No man should venture upon Snu®, who is not sure that he is not so far
liable to a cancer: and no man can be sure of that."
A.2 Excerpt on Causality from the 1964 Report to the Surgeon General
on Tobacco and Health
The 1964 Surgeon General Report on Smoking and Health marks a turning point in the history
of tobacco. By appointing a committee charged with the task of gathering evidence to the e®ect
of establishing whether there is a detrimental e®ect of tobacco on health, the Surgeon General
e®ectively brings the scholarly debate into the public arena. The introduction to the report states
that: "Few medical questions have stirred such public interest or created more scienti¯c debate
than the tobacco-health controversy. The interrelationships of smoking and health undoubtedly are
complex. The subject does not lend itself to easy answers. Nevertheless, it has been increasingly
apparent that answers must be found." The report goes on to state that the reason why answers
must be found is "to act in accordance with that evidence for the bene¯t of the people of the
United States."
The committee is composed of 10 scienti¯c members, who conduct an investigation, to which
participate over 170 individuals and a dozen of organizations among which, interestingly, one can
¯nd most of the major American tobacco companies: the American Tobacco Company, Brown &
Williamson Tobacco Corp., R.J.Reynolds Tobacco Co, Liggett & Myers, P.Lorillard Co, Phillip
Morris Inc.
After examining all evidence available to date, the committee produces a report which sum-
marises the evidence of the relationship of smoking to health, not only in terms of lung cancer,
but in terms of a large number of other conditions and mortality. The report is also very careful
to exposit what criteria have been used to assess the evidence.
As evidence, the committee uses "(1) retrospective studies which deal with data from the
personal histories and medical and mortality records of human individuals in groups; and (2)
prospective studies, in which men and women are chosen randomly or from some special group,
such as a profession, and are followed from the time of their entry into the study for an inde¯nite
period, or until they die or are lost on account of other events."
The committee reviews more than 6000 articles published in some 1200 journals, plus reports,
and other articles from various sources.Finally, tobacco companies are invited to submit statements
to the committee.
The committee's mandate is summarised by the statement: "If it be shown that an association
exists, then the question is asked: Does the association have a causal signi¯cance?" The key to
the debate, then and now, is the establishment of a causal e®ect. The committee's position on the
manner in which to establish causality is as follows:
39"Statistical methods cannot establish proof of a causal relationship in an association. The
causal signi¯cance of an association is a matter of judgment which goes beyond any statement of
statistical probability. To judge or evaluate the causal signi¯cance of the association between the
attribute or agent and the disease, or e®ect upon health, a number of criteria must be utilized, no
one of which is an all-su±cient basis for judgment. These criteria include: a) The consistency of
the association, b) The strength of the association, c) The speci¯city of the association, d) The
temporal relationship of the association, e) The coherence of the association.
On causality:
"Without summarizing the more important concepts of causality that have determined human
attitudes and actions from the days even before Aristotle, through the continuing era of observation
and experiment, to the statistical certainties of the present atomic age, the point of view of the
Committee with regard to causality and to the language used in this respect in this report may be
stated brie°y as follows:
1. The situation of smoking in relation to the health of mankind includes a host (variable
man) and a complex agent (tobacco and its products, particularly those formed by combustion in
smoking). The probe of this inquiry is into the e®ect, or non-e®ect, of components of the agent
upon the tissues, organs, and various qualities of the host which might: a) improve his well-being,
b) let him proceed normally, or c) injure his health in one way or another. To obtain information
on these points the Committee did its best, with extensive aid, to examine all available sources of
information in publications and reports and through consultation with well informed persons.
2. When a relationship or an association between smoking, or other uses of tobacco, and some
condition in the host was noted, the signi¯cance of the association was assessed.
3. The characterization of the assessment called for a speci¯c term. The chief terms considered
were factor, determinant, and cause. The Committee agreed that while a factor could be a source
of variation, not all sources of variation are causes. It is recognized that often the coexistence
of several factors is required for the occurrence of a disease, and that one of the factors may
play a determinant role, i.e., without it the other factors (as genetic susceptibility) are impotent.
Hormones in breast cancer can play such a determinant role. The word cause is the one in general
usage in connection with matters considered in this study, and it is capable of conveying the notion
of a signi¯cant, e®ectual, relationship between an agent and an associated disorder or disease in
the host.
4. It should be said at once, however, that no member of this Committee used the word cause
in an absolute sense in the area of this study. Although various disciplines and ¯elds of scienti¯c
knowledge were represented among the membership, all members shared a common conception of
the multiple etiology of biological processes. No member was so naive as to insist upon mono-
etiology in pathological processes or in vital phenomena. All were thoroughly aware of the fact
that there are series of events in occurrences and developments in these ¯elds, and that the end
results are the net e®ect of many actions and counteractions.
5. Granted that these complexities were recognized, it is to be noted clearly that the Com-
mittees considered decision to use the words a cause, or a major cause, or a signi¯cant cause, or a
causal association in certain conclusions about smoking and health a±rms their conviction."
Regarding age speci¯c mortality, the Report concludes that although there is evidence of a
statistical association, "The total number of excess deaths causally related to cigarette smoking
in the U.S. population cannot be accurately estimated. In view of the continuing and mounting
evidence from many sources, it is the judgment of the Committee that cigarette smoking contributes
substantially to mortality from certain speci¯c diseases and to the overall death rate." (Chapter 4)
40The available evidence suggests the existence of some morphological di®erences between smokers
and non-smokers, but is too meager to permit a conclusion (Chapter 15, p. 387). This does not
rule out physiological factors, especially in respect to habituation, nor the existence of predisposing
constitutional or hereditary factors (Chapter 14, p. 377).
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44Table 2: Descriptive Statistics
Variable Men Women Total
Sample size 19176 20402 39578
Proportion in the sample 0.48 0.52 1
Smokers and former smokers 0.58 0.42 0.50
Smoking prevalence 0.26 0.24 0.25
Smoking prevalence under age 30 0.22 0.30 0.26
Smoking prevalence over age 50 0.25 0.14 0.19
Average smoking duration for former smokers (years) 17.91 11.73 15.56
Average quantities of cigarettes per day for smokers 14.71 12.67 13.71
Number of deaths by 1998 3291 3302 6593
Age 46.32 48.52 47.45
Proportion with low education 0.41 0.45 0.43
medium education 0.39 0.37 0.38
high education 0.19 0.18 0.19
45Table 3: Variables Used to Construct the Tobacco-free Health Scores
Description (ICD9 code) Score 1 Score 2 Score 3 Cases
adjusted adult height X X X 39578
antibiotic prescription X 1130
poliomyelitis (40-45) X X 55
herpes (53-55) X X 32
other infectious and parasitic diseases (1-139) X 130
malignant neoplasm (140-240)a X 851
endocrine, nutritional and metabolic diseases,
and immunity disorders, excluding diabetes (240-280) X 921
diabetes, type 1 (250) X X 136
diseases of the blood and blood-forming organs (280-290) X 258
mental disorders (290-320) X X 1031
diseases of the nervous system and sense organs (320-390) X 3288
pneumoconioses due to external agents (500-509) X 23
hernia of abdominal cavity (550-554) X X 153
noninfective enteritis and colitis (555-560) X X 137
appendicitis, other diseases of X X 194
intestines (540-544, 560-570)
other diseases of digestive system (570-580) X 202
calculus (592-595) X X 181
urinary tract infection (599-600) X X 126
diseases of male genital organs (600-610) X X 184
in°ammatory disease of female pelvic organs
and other disorders of female genital tract (614-616) X X 94
amenorrhea (627) X X 60
menopausal and postmenopausal disorders (627) X X 140
hematocele (629) X X 35
psoriasis (696) X 267
diseases of the musculoskeletal system (710-740) X X 6496
headache (784) X 195
senility (797) X X 147
accidents (excluding ¯re due to smoking) (800-999) X X 2127
a excluding neoplasm of: lip, oral cavity pharynx (140-149); esophagus (150); pancreas (157);
larynx (161); trachea, lung, bronchus (162); cervix uteri (180); urinary bladder (188);kidney, other
urinary (189)
46Table 4: Selection Into Smoking: E®ect of Poor Tobacco-free Health versus Good Health.
Score 1 Score 2 Score 3
Panel A, Odds ratio, Probability of Being a Smokers (current and former)
Age> 60 1.05 [0.84, 1.31] 1.02 [0.82, 1.27] 0.88 [0.70,1.10]
Age< 50 1.19** [1.05, 1.34] 1.17** [1.03, 1.32] 1.07 [0.95,1.22]
Age< 35 1.21** [1.03, 1.42] 1.20** [1.02, 1.41] 1.17* [0.99,1.36]
Age< 25 1.36** [1.09, 1.67] 1.40** [1.12, 1.73] 1.25** [1.00,1.55]
Panel B, Odds ratio, Probability of Heavy Smoking, Conditional on Smoking.
Age> 60 0.88 [0.58 , 1.34] 0.82 [0.54 , 1.25] 0.78 [0.52, 1.17]
Age< 50 1.30** [1.09 , 1.55] 1.30** [1.09 , 1.55] 1.07 [0.89, 1.27]
Age< 35 1.27** [1.00 , 1.61] 1.37** [1.07 , 1.73] 0.99 [0.77, 1.25]
Age< 25 0.99 [0.68 , 1.45] 1.10 [0.75 , 1.60] 0.83 [0.56, 1.21]
Panel C, Odds ratio, Probability of Heavy-Smoking, Unconditional on Smoking.
Age2 [25;50] 1.79** [1.31, 2.43] 1.82** [1.34, 2.46] 1.29* [0.96, 1.72]
Panel D, Odds ratio, Probability of Starting Smoking Before Age 15.
Age< 25 1.48** [1.07, 2.05] 1.47** [1.06, 2.05] 1.20 [0.86,1.69]
Panel E, Hazard ratio, Duration to Quitting.
All Ages 0.87** [0.83, 0.92] 0.88**[0.82, 0.93] 0.88** [0.78,0.99]
Age< 35 0.91** [0.86, 0.96] 0.92** [0.86, 0.98] 0.94 [0.84,1.07]
Note: * and ** denotes signi¯cance at the 10% and 5% level. For Panel A and B,
the coe±cients are obtained by a logistic regression of an indicator for ever smoker
or for heavy smoking (more than a pack a day). For Panel C, the coe±cients were
obtained from a strati¯ed Cox duration regression. Controls are age dummies, sex,
education level, interview year e®ects, alcohol consumption, snus consumption and
risky occupation. Robust standard errors were computed. 95% con¯dence intervals
in brackets.
47Table 5: Changes in Tobacco-free Morbidity and Smoking
Score 1 Score 2
Smokers (current and former) compared to Never Smokers
All Ages 0.18 (0.17) 0.15 (0.18)
Age>40 0.27 (0.23) 0.19 (0.24)
E®ect of Quantities Smoked
All Ages 0.019 (.014) 0.02 (0.015)
Age>40 0.026 (.019) 0.027 (0.021)
E®ect of Duration of Habit, Conditional on Ever Smoker
All Ages 0.008 (.011) 0.011 (0.012)
Age>40 .003 (.012) 0.005 (0.012)
Note: Robust standard errors were computed. Regressions control
for age, sex and education levels.
Table 6: Smoking and Life Expectancy.
Sample Controls Hazard Ratio [Loss in Years]
Ever Smoker Heavy Smoker
All sex, educ. 1.31** [3.4] 1.85** [6.9]
All sex, educ., health 1.30** [3.4] 1.83** [6.9]
Poor Health sex, educ. 1.24** [3.0] 1.58** [5.5]
Good Health sex, educ. 1.45** [4.5] 1.84** [6.8]
Poor Health, low Ed. sex 1.18** [3.0] 1.27** [4.2]
Good Health, High Ed. sex 1.44** [ 4.4] 2.04** [7.8]
Note: ** denotes signi¯cance at the 5% level. Heavy Smoker de¯ned as smoking at
least a pack a day. Loss (in brackets) is de¯ned as the di®erence in life expectancy.
48Table 7: Compensation for Foregone Earnings at Age 55 (Millions of US Dollars)
Tobacco-Free Health Type Low Ed Medium Ed High Ed
Men
Good .1165 [.085, .14] .1770 [.13, .21] .2705 [.20, .34]
Average .0997 [.074, .11] .1273 [.08, .16] .2437 [.19, .29]
Bad .0908 [.062, .11] .1052 [.07, .13] .1380 [.10, .16]
Women
Good .0924 [.06, .11] .1268 [.08, .17] .1805 [.13, .21]
Average .0905 [.06, .11] .1347 [.08, .18] .1900 [.14, .22]
Bad .0784 [.05, .09] .1009 [.06, .13] .1651 [.12, .20]
Note: Numbers in brackets are computed using the 20 and 80% quantiles of
life-cycle earnings.
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